home
frankly speaking podcast

#27 David Vermijs: Last chance to influence EU Sustainability Reporting Standards

Listen to David Vermijs, Director of Business Engagement at Shift

This episode of Frankly Speaking welcomes David Vermijs and discusses the final draft of the first set of European Sustainability Reporting Standards (ESRS). 

The draft Delegated Act from the European Commission is currently subject to a feedback period until the 7th of July. He is also a member of EFRAG's Sustainability Reporting Board, the body which undertakes the technical work to recommend the new sustainability reporting standards.

You will hear more about:

  • the draft proposed by the European Commission and how it differs from EFRAG's recommendations
  • how the first set of ESRS needs to look like to be effective
  • the opinion coming from the business and investement community
  • the role of the EU in the development of robust sustainability reporting standards worldwide

Listen in and follow us on Twitter and LinkedIn!

“Some of the biggest leaders in our world, including indeed the president von der Leyen, also President Biden, Emmanuel Macron gave this very message, saying that, yes, we need a transition, but we need a transition towards a climate neutral economy leaving no one behind. We got to make sure that that also comes through in the reporting standards. We do want the reporting to be meaningful and to be representative of what's happening in practice.”

David Vermijs in Frankly Speaking

You may also like these episodes

36:58

#28 Allan Jorgensen: What the OECD Guidelines update means for responsible business

Listen to Allan Jorgensen, Head of the OECD Centre for Responsible Business Conduct.

30:54

#26 Giulia Bondi: Unpacking the new EU Deforestation Regulation

Listen to Giulia Bondi, Senior EU Campaigner, lead for Forests at the investigatory organisation Global Witness.

31:40

#25 Sonja Haut: Why ‘impact’ of the business is the next big thing

Listen to Sonja Haut, Head of Impact Valuation at pharmaceuticals company Novartis and member of the World Economic Forum Futures Council.